{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T18:36:11Z","timestamp":1791916571034,"version":"4.3.4"},"reference-count":5,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T00:00:00Z","timestamp":1498262400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology Case Reports"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.ajoc.2018.01.032","type":"journal-article","created":{"date-parts":[[2018,1,11]],"date-time":"2018-01-11T14:22:37Z","timestamp":1515680557000},"page":"77-79","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Intravitreal rituximab for the treatment of a secondary intraocular relapse of a large B-cell lymphoma"],"prefix":"10.1016","volume":"9","author":[{"given":"Jose J.","family":"Echegaray","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Llop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Sepulveda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roman","family":"Velez-Rosario","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7194-8649","authenticated-orcid":false,"given":"Noel","family":"Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armando L.","family":"Oliver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ajoc.2018.01.032_bib1","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1080\/09273940902957305","article-title":"Epidemiology and clinical features of intraocular lymphoma","volume":"17","author":"Mochizuki","year":"2009","journal-title":"Ocul Immunol Inflamm"},{"issue":"9","key":"10.1016\/j.ajoc.2018.01.032_bib2","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1001\/jamaophthalmol.2013.334","article-title":"Vitreoretinal presentation of secondary large b-cell lymphoma in patients with systemic lymphoma","volume":"131","author":"Salomao","year":"2013","journal-title":"JAMA Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajoc.2018.01.032_bib3","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/IAE.0b013e318192f574","article-title":"Rituximab for intraocular lymphoma","volume":"29","author":"Itty","year":"2009","journal-title":"Retina"},{"issue":"3","key":"10.1016\/j.ajoc.2018.01.032_bib4","doi-asserted-by":"crossref","first-page":"668","DOI":"10.4103\/0973-1482.140824","article-title":"Therapeutic vitrectomy for vitreal recurrence of intraocular lymphoma resistant to intravitreal methotrexate post systemic chemotherapy","volume":"11","author":"Venkatesh","year":"2015","journal-title":"J Canc Res Therapeut"},{"key":"10.1016\/j.ajoc.2018.01.032_bib5","first-page":"1","article-title":"Transient therapeutic effect of vitrectomy in primary intraocular lymphoma","author":"Iaccheri","year":"2016","journal-title":"Int Ophthalmol"}],"container-title":["American Journal of Ophthalmology Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451993617301998?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451993617301998?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T14:55:57Z","timestamp":1762527357000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2451993617301998"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":5,"alternative-id":["S2451993617301998"],"URL":"https:\/\/doi.org\/10.1016\/j.ajoc.2018.01.032","relation":{},"ISSN":["2451-9936"],"issn-type":[{"value":"2451-9936","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intravitreal rituximab for the treatment of a secondary intraocular relapse of a large B-cell lymphoma","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajoc.2018.01.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}